Zacks Investment Research
16 Jul 2026, 18:51 UTC · 1h ago
MITQ Rallies 17% in the Past Month: Should You Buy the Stock?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
16 Jul 2026, 18:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Moving iMage Technologies (MITQ) expanded its gross margin to 31.5% from 27.5% year-over-year for the first nine months of fiscal 2026. — Direct improvement in profitability and margin expansion is a strong positive catalyst for a microcap company's valuation.
+0.60MITQ's shares have gained 17.2% over the past month, significantly outperforming its industry which declined by 2.1%. — Strong relative strength indicates positive momentum and investor confidence compared to peers.
+0.40Moving iMage Technologies acquired QSC's Digital Cinema Speaker Series (DCS) to expand into the premium cinema audio market. — Strategic acquisitions for market expansion and higher-margin revenue streams are generally positive for growth prospects.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
Shares gained 17.2%, outperforming the industry with improving profitability and successful acquisition integration.
Shares declined 8.2% over the past month.
Shares rallied 3.3% but underperformed relative to MITQ.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
2h ago